Debra Patt, MD, PhD, MBA, MPH, discusses AI adoption, administrative burden, and strategies to streamline prior authorization in oncology.
|Articles|March 28, 2011
HIT Press Club AJMC - Audience Q&A Session with the Panelists
Author(s)Sachin Jain, MD, MBA
The Q&A Session from the Healthcare Innovations and HIT Q&A Session at the National Press Club in Washington, DC.
Advertisement
The Q&A Session from the Healthcare Innovations and HIT Q&A Session at the National Press Club in Washington, DC.
Advertisement
Related to this article
Patient factors and access barriers are reshaping treatment sequencing and individualized care for relapsed multiple myeloma, Amandeep Godara, MBBS, said.
Christos Vaklavas, MD, discussed barriers limiting rural oncology access and challenges to adopting resource-intensive therapies.
Shiven B. Patel, MD, MBA, shares strategies for closing biomarker testing gaps, including for patients with non–small cell lung cancer.
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Finerenone Approval to CKD Associated With Type 1 Diabetes
2
Twice-Yearly CD19 Therapy Targets MG Root Cause: Richard Nowak, MD, MS
3
GLP-1 Receptor Agonists Cut Ascites, Mortality in MASH
4
Hepatitis A Vaccine Prevents 96% of Infections Given Before Exposure
5